Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy
about
Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugsThe cell surface mucin podocalyxin regulates collective breast tumor budding.PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.miR-509-3-5P inhibits the invasion and lymphatic metastasis by targeting PODXL and serves as a novel prognostic indicator for gastric cancer.Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma.Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma.Prognostic role of podocalyxin-like protein expression in various cancers: A systematic review and meta-analysis.Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancerDNA methylation map in circulating leukocytes mirrors subcutaneous adipose tissue methylation pattern: a genome-wide analysis from non-obese and obese patients.Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma.Dopamine D2 receptor antagonist sulpiride enhances dexamethasone responses in the treatment of drug-resistant and metastatic breast cancer.Expression of Tim4 in Glioma and its Regulatory Role in LN-18 Glioma Cells.Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development.Podocalyxin promotes proliferation and survival in mature B-cell non-Hodgkin lymphoma cells.Keratan Sulphate, a complex Glycosaminoglycan with Unique Functional Capability.Cycling CD34 expression in subpopulations of head and neck squamous cell carcinoma cell lines is involved in radioresistance and change in cytokeratin expression profile.Genetically Encoded Toolbox for Glycocalyx Engineering: Tunable Control of Cell Adhesion, Survival, and Cancer Cell Behaviors.Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma.Determination of critical epitope of PcMab-47 against human podocalyxin.Cancer stem cells as targets for DC-based immunotherapy of colorectal cancerPodocalyxin is crucial for the growth of oral squamous cell carcinoma cell line HSC-2Conservation of oncofetal antigens on human embryonic stem cells enables discovery of monoclonal antibodies against cancer
P2860
Q26777335-9927BF98-74F6-4841-B3D1-842F083AD48EQ27338644-5119F611-AAB0-4B61-B91E-0A5EB5E8B816Q33600992-34D339DF-E81D-4164-B261-F32C307A4D0FQ33798629-EF8E1FA3-E9CE-4587-A3DA-DAD4BE4DC51BQ35647464-1D6D168F-D5F5-463E-AA44-E51CF3CC74ABQ36091414-B64855AB-9A84-4B25-9E23-4E1068BA7198Q36236781-907FE867-F4FD-4ACA-A0A3-34605925B55BQ36886612-9F2E3DDC-CCEC-41D5-8511-564471EA4ACEQ37649597-2C02C2D6-6EEC-4495-8EDB-C7E36C9240CEQ37735632-E168E33B-468A-4179-A75C-BDF56AEADDFDQ38709654-CC5B32F3-F9D0-4D0D-81A4-BDC09C599583Q38805940-95752947-9E9E-4788-A139-7FF04EEADFB8Q42515034-A6615F63-0E1F-4287-A28D-819940417F4CQ46238878-7B84ACC0-8426-4D65-AD1D-882F7BA0C91FQ47860795-8802177E-C8D6-423A-8C6B-2BD0B98E3904Q52837382-316A973D-46A3-44EE-9A2B-1FA140318276Q54977954-A50CDBBC-3B59-444E-B1CC-9F1FCD38B819Q55249763-2B9C76F0-AEA0-4F0C-B795-9F710E9DF2A6Q55316843-BC159217-E351-4A03-B52E-4596C8DF8D7CQ58786746-6A59B90E-5850-4120-8789-D84861D61DB7Q58797407-542F26F6-4EBB-4DE9-A469-1077F8C1FCAEQ58803669-62DA4B3B-5091-44DE-8147-E9FFAF755229
P2860
Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapy
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Podocalyxin enhances breast tu ...... or monoclonal antibody therapy
@ast
Podocalyxin enhances breast tu ...... or monoclonal antibody therapy
@en
Podocalyxin enhances breast tu ...... or monoclonal antibody therapy
@en-gb
Podocalyxin enhances breast tu ...... or monoclonal antibody therapy
@nl
type
label
Podocalyxin enhances breast tu ...... or monoclonal antibody therapy
@ast
Podocalyxin enhances breast tu ...... or monoclonal antibody therapy
@en
Podocalyxin enhances breast tu ...... or monoclonal antibody therapy
@en-gb
Podocalyxin enhances breast tu ...... or monoclonal antibody therapy
@nl
prefLabel
Podocalyxin enhances breast tu ...... or monoclonal antibody therapy
@ast
Podocalyxin enhances breast tu ...... or monoclonal antibody therapy
@en
Podocalyxin enhances breast tu ...... or monoclonal antibody therapy
@en-gb
Podocalyxin enhances breast tu ...... or monoclonal antibody therapy
@nl
P2093
P2860
P3181
P1476
Podocalyxin enhances breast tu ...... or monoclonal antibody therapy
@en
P2093
Bradley Hedberg
Calvin D Roskelley
Diana Canals Hernaez
Frederic Cruz
Jill Brandon
John A Wilkins
John S Babcook
Julie S Nielsen
Kelly M McNagny
P2860
P2888
P3181
P356
10.1186/S13058-015-0562-7
P407
P577
2015-01-01T00:00:00Z
P5875
P6179
1045750258